Company intelligence / Profile preview
Dalian Aleph Biomedical
Dalian, Liaoning, China
- Ownership
- Private
- Employees
- ~35
- Development stage
- Other
01
Overview
Dalian Aleph Biomedical, now integrated as Fosun Aleph (Dalian) Biomedical, develops and manufactures approved prophylactic vaccines for human use, including influenza and rabies vaccines; these have received regulatory approvals in China since 2009, with the most recent rabies vaccine approval in 2024[1][5][8].
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccineBiologic
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Dalian Aleph Biomedical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dalian Aleph Biomedical.